14.85 stock price up
Change
+ 0.40 (2.77%)
Volume
2,200
Exchange
NASDAQ
3:21 PM ET on Aug 29, 2014
Delayed at least 20 minutes.
Provided by eSignal.
5.10 stock price up
Change
+ 0.05 (0.91%)
Volume
1,202
Exchange
TASE
6:51 AM IT on Sep 1, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Aug 27, 2014
RedHill Biopharma Provides Update on Expansion of Ongoing RHB-105 Phase III Study, Targeting Broadened H. pylori Indication Authorized by FDA

Aug 13, 2014
RedHill Biopharma Acquires Option for Phase II Pancreatic Cancer Drug RP101

Jul 23, 2014
RedHill Biopharma Reports Results for the Second Quarter of 2014

View all »Upcoming Events & Presentations

Sep 4, 2014 at 8:30 AM
RedHill Presentation - Gelbart Kahana Biomed Conference
Hilton Tel-Aviv

Sep 8, 2014 - Sep 10, 2014
Rodman & Renshaw 16th Annual Global Investment Conference
New-York Palace Hotel, NYC

Sep 22, 2014 - Sep 24, 2014
BioPharm America 2014
Boston, MA, USA

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com